|
000
| 01787nam 2200385zi 4500 |
|---|
| 001 | 9.900586 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107175439 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 210609e202107##onc ob f000 0 eng d |
|---|
| 020 | |a9780660391786 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH22-4/24-1-2021E-PDF |
|---|
| 245 | 00|aBuilding a national strategy for high-cost drugs for rare diseases : |bwhat we heard from Canadians. |
|---|
| 264 | 1|aOttawa, ON : |bGovernment of Canada = Gouvernement du Canada, |cJuly 2021. |
|---|
| 264 | 4|c©2021 |
|---|
| 300 | |a1 online resource (25 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued by: Health Canada. |
|---|
| 500 | |aIssued also in French under title: Élaboration d'une stratégie nationale sur les médicaments pour le traitement des maladies rares : ce que nous avons entendu des canadiens. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 650 | 0|aDrugs|xPrices|zCanada|xPublic opinion. |
|---|
| 650 | 0|aRare diseases|zCanada|xPublic opinion. |
|---|
| 650 | 0|aPharmaceutical policy|zCanada|xPublic opinion. |
|---|
| 650 | 0|aPublic opinion|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tÉlaboration d'une stratégie nationale sur les médicaments pour le traitement des maladies rares : |w(CaOODSP)9.900587 |
|---|
| 856 | 40|qPDF|s1.58 MB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H22-4-24-1-2021-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/programs/consultation-national-strategy-high-cost-drugs-rare-diseases-online-engagement/what-we-heard.html |
|---|